Juntao Zhuang
No. 300 Guangzhou Road
Nanjing, 210029, China
Nanjing, 210029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
PD-L1+ CTCs Are Associated with Adverse Pathological Features and Unfavorable Prognosis in Bladder Cancer.
Journal: Diagnostics (Basel, Switzerland)
Published: March 01, 2026
Prone retroperitoneal versus lateral retroperitoneal robotic assisted partial nephrectomy: a propensity score-matched comparison.
Journal: World journal of urology
Published: December 06, 2025
HDAC10 suppresses anti-tumour immunity by inhibiting ILF3-CXCL9 axis to block CD8+ T cell infiltration and activation in bladder cancer.
Journal: Cancer letters
Published: December 05, 2025
Consolidative Radical Cystectomy Following Neoadjuvant Tislelizumab Plus Gemcitabine and Cisplatin in Clinically Lymph Node-positive Bladder Cancer: A Prospective Study.
Journal: European urology open science
Published: November 14, 2025
Development and validation of MRI-based models to predict lymph node metastasis in bladder cancer: a multi-center study.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: September 11, 2025
Potential of Urinary Mutation and Methylation Biomarkers in Selecting Candidates for Repeat Transurethral Resection of Bladder Tumor in Non-muscle-invasive Bladder Cancer: A Prospective Multicenter Study.
Journal: European urology open science
Published: May 24, 2025
A nomogram including body composition parameters for predicting recurrence of pT1 clear cell renal cell carcinoma: a multicenter retrospective study.
Journal: Insights into imaging
Published: April 27, 2025
Prone retroperitoneal robotic-assisted laparoscopic radical nephroureterectomy with bladder cuff excision in single position: techniques and outcomes.
Journal: Journal of robotic surgery
Published: January 31, 2025
SRSF1-mediated alternative splicing regulates bladder cancer progression and cisplatin sensitivity through HIF1A/BNIP3/mitophagy axis.
Journal: Journal of translational medicine
Published: October 23, 2024
IGF2BP3 promotes the proliferation and cisplatin resistance of bladder cancer by enhancing the mRNA stability of CDK6 in an m6A dependent manner.
Journal: International journal of biological sciences
Published: September 11, 2024
CircFAM64A(3) promoted bladder cancer proliferation and inhibited CD8 + T cell via sponging to miR-149-5p and activated IL-6/JAK/STAT pathway.
Journal: International immunopharmacology
Published: August 07, 2024
Last Updated: 09/26/2026